In the early-onset RA patients MTX reduced the ratio of Th17 cells among helper T cells but not those of Th1 cells or Th17∙Th1 cells (Th cells producing both IFN-γ and IL-17). The gene discussed is IL17A; the disease is rheumatoid arthritis.